Community-reported Anagrelide side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Anagrelide Side Effect Episode
Have You dealt with a Anagrelide side effect? Share your experience
Review Anagrelide Safety Reports submitted to FDA
Total Anagrelide reports: 23.Anagrelide FDA safety alerts: 2005 .
Reported deaths: 4 Reported hospitalizations: 12.
Take Anagrelide Side Effects Survey, Discuss Anagrelide with others
FDA Reported Anagrelide Side Effects: dizziness, platelet count increased, asthenia, myelofibrosis, renal impairment, migraine with aura, headache, oedema peripheral, gastrointestinal haemorrhage, cerebrovascular accident, dyspnoea.
More About Anagrelide.
If you have questions about Anagrelide, you can ask a Health Expert or Ask Patient Community about Anagrelide.
Anagrelide Side Effects Report #5653037-9
Physician from UNITED KINGDOM reported ANAGRELIDE problem on Feb 28, 2008. Female patient, 65 years of age, weighting 132.3 lb, was diagnosed with myeloproliferative disorder, iron overload and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, arthralgia, blood albumin decreased, blood alkaline phosphatase increased, diarrhoea, vomiting. ANAGRELIDE dosage: 4 MG. During the same period patient was treated with HYDROXYCARBAMIDE, ASPIRIN, LANSOPRAZOLE, EXJADE. Patient was hospitalized and became disabled. Patient recovered.
Anagrelide Side Effects Report #5660959-1
ANAGRELIDE problem was reported by a Physician from NETHERLANDS on Feb 21, 2008. Male patient, 76 years of age, weighting 112.4 lb, was diagnosed with myeloproliferative disorder and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: hypotension, pancytopenia, syncope. ANAGRELIDE dosage: 0.5 MG,. During the same period patient was treated with PANTOZOL, ASCAL, LABETALOL, LASIX, ALDACTONE, APROVEL, COVERSYL, CARDURA. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5682452-2
Pharmacist from UNITED STATES reported ANAGRELIDE problem on Mar 26, 2008. Female patient, weighting 173.7 lb, was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, pulmonary hypertension, right ventricular failure. ANAGRELIDE dosage: 0.5 MG BID PO. Patient was hospitalized and became disabled. Patient recovered.
Anagrelide Side Effects Report #5683882-5
ANAGRELIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2008. Female patient, 77 years of age, weighting 118.0 lb, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral, pain in extremity, wheelchair user. ANAGRELIDE dosage: unknown. Patient recovered.
Anagrelide Side Effects Report #5688192-8
Physician from SWEDEN reported ANAGRELIDE problem on Mar 12, 2008. Male patient was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, platelet count decreased. ANAGRELIDE dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.
Anagrelide Side Effects Report #5619214-8
ANAGRELIDE problem was reported by a Consumer or non-health professional from GERMANY on Jan 21, 2008. Male patient, 38 years of age, was diagnosed with thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: dermatitis, skin necrosis, skin ulcer. ANAGRELIDE dosage: 2 X 500 MG. Patient recovered.
Anagrelide Side Effects Report #5632191-9
Consumer or non-health professional from GERMANY reported ANAGRELIDE problem on Feb 01, 2008. Male patient, 38 years of age, was diagnosed with thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: atrophie blanche, dermatitis, erythema, necrobiosis, pain, platelet count increased, skin ulcer. ANAGRELIDE dosage: 2 X 500 MG;. During the same period patient was treated with ASPIRIN, ALLOPURINOL, LISINOPRIL, BISOPROLOL FUMARATE. Patient recovered.
Anagrelide Side Effects Report #5608243-6
ANAGRELIDE problem was reported by a Health Professional from FRANCE on Jan 11, 2008. Female patient, 28 years of age, was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: cutaneous vasculitis, oedema peripheral, skin exfoliation, skin necrosis, telangiectasia, ulcer. ANAGRELIDE dosage: 0.5 MG, ORAL. During the same period patient was treated with CALCIPARINE, LASILIX, SPECIAFOLDINE, TOPALGIC, AMLODIPINE BESYLATE, ADVIL, OFLOCET, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5548304-3
Health Professional from FRANCE reported ANAGRELIDE problem on Nov 23, 2007. Male patient, 54 years of age, was diagnosed with thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, epilepsy, hypokalaemia, ischaemic stroke. ANAGRELIDE dosage: 2.5 MG TOTAL DAILY DOSE, ORAL. Patient recovered.
Anagrelide Side Effects Report #5553880-0
ANAGRELIDE problem was reported by a Pharmacist from UNITED STATES on Dec 12, 2007. Female patient, 28 years of age, was diagnosed with thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ANAGRELIDE dosage: 3.5 MG PER DAY PO. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5574013-0
Physician from GERMANY reported ANAGRELIDE problem on Dec 11, 2007. Female patient, 73 years of age, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pulmonary embolism, pulmonary fibrosis, renal impairment. ANAGRELIDE dosage: 2.5 MG DAILY, ORAL, 2.5 MG DAILY, ORAL. During the same period patient was treated with BUSULFAN, HYDROXYUREA. Patient was hospitalized. Patient died on 11/03/2006.
Anagrelide Side Effects Report #5574014-2
ANAGRELIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 11, 2007. Male patient, 51 years of age, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. ANAGRELIDE dosage: 2 MG, 1X/DAY: QD, ORAL, 1.5 MG, OTHER, ORAL, 1 MG, 1X/DAY: QD, ORAL, 1.5 MG, 2X/DAY: BID, ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, LEVOTHYROXINE. Patient died on 12/08/2007.
Anagrelide Side Effects Report #5580995-3
Physician from UNITED KINGDOM reported ANAGRELIDE problem on Dec 18, 2007. Female patient, 90 years of age, was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: axillary mass, blood albumin decreased, blood glucose increased, blood sodium decreased, blood thyroid stimulating hormone increased, creatine phosphokinase decreased, eosinophil count increased, haematocrit decreased, haemoglobin decreased. ANAGRELIDE dosage: unknown. During the same period patient was treated with CORSODYL. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5521563-9
ANAGRELIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2007. Male patient, 56 years of age, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia. ANAGRELIDE dosage: 1 MG DAILY, } 1 MG DAILY. During the same period patient was treated with ASPIRIN. Patient recovered.
Anagrelide Side Effects Report #5522873-1
Pharmacist from UNITED STATES reported ANAGRELIDE problem on Nov 02, 2007. Female patient, 84 years of age, was diagnosed with thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: platelet count increased, transient ischaemic attack. ANAGRELIDE dosage: 3 MG, QD, ORAL. During the same period patient was treated with ASPIRIN, CALCIUM, DILTIAZEM, JANUMET, LEVOTHYROXINE, PAXIL, PLAVIX. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5500112-5
ANAGRELIDE problem was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, 78 years of age, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: vasculitis necrotising. ANAGRELIDE dosage: 0.5 MG, 4X/DAY:QID, ORAL. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5504730-X
Physician from GREECE reported ANAGRELIDE problem on Oct 16, 2007. Female patient, 48 years of age, was diagnosed with thrombocytopenia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia. ANAGRELIDE dosage: unknown. Patient recovered.
Anagrelide Side Effects Report #5456603-9
ANAGRELIDE problem was reported by a Pharmacist from UNITED STATES on Sept 17, 2007. Male patient, 70 years of age, was diagnosed with thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: dizziness, dyspnoea, headache, presyncope. ANAGRELIDE dosage: 2MG BID PO. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5466223-8
Physician from FRANCE reported ANAGRELIDE problem on Sept 04, 2007. Female patient, 61 years of age, was diagnosed with thrombocytopenia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, migraine with aura. ANAGRELIDE dosage: 0.5 MG, 2X/DAY: BID, ORAL; 0.75 MG, 2X/DAY: BID, ORAL; 1 MG, 2X/DAY: BID, ORAL. During the same period patient was treated with PIPOBROMAN. Patient recovered.
Anagrelide Side Effects Report #5467235-0
ANAGRELIDE problem was reported by a Consumer or non-health professional from GREECE on Sept 07, 2007. Female patient was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: oedema, pulmonary oedema, rash, renal failure acute. ANAGRELIDE dosage: 1 MG, 2X/DAY: BID, ORAL. During the same period patient was treated with HYDROXYUREA. Patient was hospitalized. Patient died on 11/10/2006.
Anagrelide Side Effects Report #5472449-X
Physician from GREECE reported ANAGRELIDE problem on Sept 10, 2007. Male patient was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspepsia, helicobacter infection, nausea, vomiting. ANAGRELIDE dosage: 1 MG, OTHER, ORAL. During the same period patient was treated with PLAVIX, ZANTAC. Patient recovered.
Anagrelide Side Effects Report #5385895-X
ANAGRELIDE problem was reported by a Physician from FRANCE on June 27, 2007. Female patient, 61 years of age, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, migraine with aura. ANAGRELIDE dosage: unknown. During the same period patient was treated with PIPOBROMAN. Patient recovered.
Anagrelide Side Effects Report #5385895-X
Physician from FRANCE reported ANAGRELIDE problem on June 27, 2007. Female patient, 61 years of age, was diagnosed with essential thrombocythaemia and was treated with ANAGRELIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, migraine with aura. ANAGRELIDE dosage: unknown. During the same period patient was treated with PIPOBROMAN. Patient recovered.